ABT vs SBDS · P/E 25, rev $44.33B vs rev $151.3M
Abbott Laboratories (ABT) versus Solo Brands, Inc. (SBDS) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Solo Brands, Inc. (SBDS) is a internet retail company listed on NYSE.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported SBDS revenue for 2026-06-30 was $151.3M. Net income was -$9.9M. SBDS currently screens at market cap $10.0M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. SBDS currently screens at market cap $10.0M.
Not investment advice. Open the ABT and SBDS stock pages for the full models.
Not investment advice.